LCBSX | PMAQX | LCBSX / PMAQX | |
Total Expense Ratio | 1.37 | 0.59 | 232% |
Annual Report Gross Expense Ratio | 1.37 | 0.59 | 232% |
Fund Existence | 13 years | 9 years | - |
Gain YTD | -2.269 | 2.039 | -111% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.36B | 30.6B | 11% |
Annual Yield % from dividends | 0.00 | 0.19 | - |
Returns for 1 year | 13.74 | 10.62 | 129% |
Returns for 3 years | 52.76 | 50.92 | 104% |
Returns for 5 years | 60.56 | 56.82 | 107% |
Returns for 10 years | 222.00 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FDNI | 33.29 | N/A | N/A |
First Trust Dow Jones Intl Intnt ETF | |||
JAAA | 50.65 | -0.01 | -0.02% |
Janus Henderson AAA CLO ETF | |||
GHYG | 45.45 | -0.15 | -0.32% |
iShares US & Intl High Yield Corp Bd ETF | |||
BNDW | 68.77 | -0.23 | -0.33% |
Vanguard Total World Bond ETF | |||
HQL | 12.85 | -0.13 | -1.00% |
abrdn Life Sciences Investors |